Advancing Reliable Data for Cancer Control in the Central America Four Region

The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices,...

Full description

Bibliographic Details
Main Authors: Marion Piñeros, Silvina Frech, Lindsay Frazier, Mathieu Laversanne, Joaquin Barnoya, Claudia Garrido, Eduardo Gharzouzi, Andrea Chacón, Soad Fuentes Alabi, Lisseth Ruiz de Campos, Jacqueline Figueroa, Ricardo Dominguez, Ofelia Rojas, Rosario Pereira, Carla Rivera, Douglas R. Morgan
Format: Article
Language:English
Published: American Society of Clinical Oncology 2018-12-01
Series:Journal of Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/JGO.2016.008227
_version_ 1819047511649681408
author Marion Piñeros
Silvina Frech
Lindsay Frazier
Mathieu Laversanne
Joaquin Barnoya
Claudia Garrido
Eduardo Gharzouzi
Andrea Chacón
Soad Fuentes Alabi
Lisseth Ruiz de Campos
Jacqueline Figueroa
Ricardo Dominguez
Ofelia Rojas
Rosario Pereira
Carla Rivera
Douglas R. Morgan
author_facet Marion Piñeros
Silvina Frech
Lindsay Frazier
Mathieu Laversanne
Joaquin Barnoya
Claudia Garrido
Eduardo Gharzouzi
Andrea Chacón
Soad Fuentes Alabi
Lisseth Ruiz de Campos
Jacqueline Figueroa
Ricardo Dominguez
Ofelia Rojas
Rosario Pereira
Carla Rivera
Douglas R. Morgan
author_sort Marion Piñeros
collection DOAJ
description The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices, and unified with open borders in 2006. The growing CA-4 cancer burden among the noncommunicable diseases is expected to increase 73% by 2030, which argues for a regional approach to cancer control. This has driven efforts to establish population-based cancer registries as a central component of the cancer control plans. The involvement of international and academic partners in an array of initiatives to improve cancer information and control in the CA-4 has accelerated over the past several years. Existing data underscore that the infectious cancers (cervical, stomach, and liver) are a particular burden. All four countries have committed to establishing regional population-based cancer registries and have advanced significantly in pediatric cancer registration. The challenges common to each nation include the lack of national cancer control plans and departments, competing health priorities, lack of trained personnel, and sustainability strategies. General recommendations to address these challenges are outlined. The ongoing regional, international, and academic cooperation has proven helpful and is expected to continue to be a powerful instrument to contribute to the design and implementation of long-term national cancer control plans.
first_indexed 2024-12-21T11:01:32Z
format Article
id doaj.art-df48951e946645ac9b00d81220dc327d
institution Directory Open Access Journal
issn 2378-9506
language English
last_indexed 2024-12-21T11:01:32Z
publishDate 2018-12-01
publisher American Society of Clinical Oncology
record_format Article
series Journal of Global Oncology
spelling doaj.art-df48951e946645ac9b00d81220dc327d2022-12-21T19:06:20ZengAmerican Society of Clinical OncologyJournal of Global Oncology2378-95062018-12-01411110.1200/JGO.2016.0082271Advancing Reliable Data for Cancer Control in the Central America Four RegionMarion Piñeros0Silvina Frech1Lindsay Frazier2Mathieu Laversanne3Joaquin Barnoya4Claudia Garrido5Eduardo Gharzouzi6Andrea Chacón7Soad Fuentes Alabi8Lisseth Ruiz de Campos9Jacqueline Figueroa10Ricardo Dominguez11Ofelia Rojas12Rosario Pereira13Carla Rivera14Douglas R. Morgan15Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices, and unified with open borders in 2006. The growing CA-4 cancer burden among the noncommunicable diseases is expected to increase 73% by 2030, which argues for a regional approach to cancer control. This has driven efforts to establish population-based cancer registries as a central component of the cancer control plans. The involvement of international and academic partners in an array of initiatives to improve cancer information and control in the CA-4 has accelerated over the past several years. Existing data underscore that the infectious cancers (cervical, stomach, and liver) are a particular burden. All four countries have committed to establishing regional population-based cancer registries and have advanced significantly in pediatric cancer registration. The challenges common to each nation include the lack of national cancer control plans and departments, competing health priorities, lack of trained personnel, and sustainability strategies. General recommendations to address these challenges are outlined. The ongoing regional, international, and academic cooperation has proven helpful and is expected to continue to be a powerful instrument to contribute to the design and implementation of long-term national cancer control plans.https://ascopubs.org/doi/10.1200/JGO.2016.008227
spellingShingle Marion Piñeros
Silvina Frech
Lindsay Frazier
Mathieu Laversanne
Joaquin Barnoya
Claudia Garrido
Eduardo Gharzouzi
Andrea Chacón
Soad Fuentes Alabi
Lisseth Ruiz de Campos
Jacqueline Figueroa
Ricardo Dominguez
Ofelia Rojas
Rosario Pereira
Carla Rivera
Douglas R. Morgan
Advancing Reliable Data for Cancer Control in the Central America Four Region
Journal of Global Oncology
title Advancing Reliable Data for Cancer Control in the Central America Four Region
title_full Advancing Reliable Data for Cancer Control in the Central America Four Region
title_fullStr Advancing Reliable Data for Cancer Control in the Central America Four Region
title_full_unstemmed Advancing Reliable Data for Cancer Control in the Central America Four Region
title_short Advancing Reliable Data for Cancer Control in the Central America Four Region
title_sort advancing reliable data for cancer control in the central america four region
url https://ascopubs.org/doi/10.1200/JGO.2016.008227
work_keys_str_mv AT marionpineros advancingreliabledataforcancercontrolinthecentralamericafourregion
AT silvinafrech advancingreliabledataforcancercontrolinthecentralamericafourregion
AT lindsayfrazier advancingreliabledataforcancercontrolinthecentralamericafourregion
AT mathieulaversanne advancingreliabledataforcancercontrolinthecentralamericafourregion
AT joaquinbarnoya advancingreliabledataforcancercontrolinthecentralamericafourregion
AT claudiagarrido advancingreliabledataforcancercontrolinthecentralamericafourregion
AT eduardogharzouzi advancingreliabledataforcancercontrolinthecentralamericafourregion
AT andreachacon advancingreliabledataforcancercontrolinthecentralamericafourregion
AT soadfuentesalabi advancingreliabledataforcancercontrolinthecentralamericafourregion
AT lissethruizdecampos advancingreliabledataforcancercontrolinthecentralamericafourregion
AT jacquelinefigueroa advancingreliabledataforcancercontrolinthecentralamericafourregion
AT ricardodominguez advancingreliabledataforcancercontrolinthecentralamericafourregion
AT ofeliarojas advancingreliabledataforcancercontrolinthecentralamericafourregion
AT rosariopereira advancingreliabledataforcancercontrolinthecentralamericafourregion
AT carlarivera advancingreliabledataforcancercontrolinthecentralamericafourregion
AT douglasrmorgan advancingreliabledataforcancercontrolinthecentralamericafourregion